Enliven Therapeutics Net Debt Growth & History (ELVN)

Enliven Therapeutics's net debt was −$98.5M for fiscal 2025.

View full Enliven Therapeutics company overview

Enliven Therapeutics annual net debt history

Enliven Therapeutics annual net debt

Fiscal yearPeriod endedNet debtChangeGrowth
20252025-12-31−$98.5M$25.6M
20242024-12-31−$124.1M−$24.3M
20232023-12-31−$99.8M−$24.6M
20222022-12-31−$75.2M−$27.6M
20212021-12-31−$47.7M

Enliven Therapeutics net debt trends

Between the periods ended 2021-12-31 and 2025-12-31, Enliven Therapeutics's net debt decreased from −$47.7M to −$98.5M, a change of −$50.8M. The latest reported quarter, Q2 2026, shows −$134.0M.

About the metric

What net debt means

Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.

Calculation and source

How net debt is calculated

TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Enliven Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about ELVN yet. Start the conversation.

Write the first post